These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18006915)

  • 1. Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
    Garcia-Closas M; Troester MA; Qi Y; Langerød A; Yeager M; Lissowska J; Brinton L; Welch R; Peplonska B; Gerhard DS; Gram IT; Kristensen V; Børresen-Dale AL; Chanock S; Perou CM
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2269-75. PubMed ID: 18006915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence that GATA3 rs570613 SNP modifies breast cancer risk.
    Johnatty SE; Couch FJ; Fredericksen Z; Tarrell R; Spurdle AB; Beesley J; Chen X; ; ; ; Gschwantler-Kaulich D; Singer CF; Fuerhauser C; Fink-Retter A; Domchek SM; Nathanson KL; Pankratz VS; Lindor NM; Godwin AK; Caligo MA; Hopper J; Southey MC; Giles GG; Justenhoven C; Brauch H; Hamann U; Ko YD; Heikkinen T; Aaltonen K; Aittomäki K; Blomqvist C; Nevanlinna H; Hall P; Czene K; Liu J; Peock S; Cook M; Platte R; Gareth Evans D; Lalloo F; Eeles R; Pichert G; Eccles D; Davidson R; Cole T; Cook J; Douglas F; Chu C; Hodgson S; Paterson J; Hogervorst FB; Rookus MA; Seynaeve C; Wijnen J; Vreeswijk M; Ligtenberg M; van der Luijt RB; van Os TA; Gille HJ; Blok MJ; ; Issacs C; Humphreys MK; McGuffog L; Healey S; Sinilnikova O; Antoniou AC; Easton DF; Chenevix-Trench G;
    Breast Cancer Res Treat; 2009 Sep; 117(2):371-9. PubMed ID: 19082709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
    Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
    Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
    Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
    Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and mutational analysis of GATA3 in Malaysian breast carcinomas.
    Bong PN; Zakaria Z; Muhammad R; Abdullah N; Ibrahim N; Emran NA; Syed Hussain SN
    Malays J Pathol; 2010 Dec; 32(2):117-22. PubMed ID: 21329183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.
    Gaudet MM; Chanock S; Lissowska J; Berndt SI; Yang XR; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Sherman ME; Sutter TR; Garcia-Closas M
    Pharmacogenet Genomics; 2006 Aug; 16(8):547-53. PubMed ID: 16847423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.
    Pooley KA; Healey CS; Smith PL; Pharoah PD; Thompson D; Tee L; West J; Jordan C; Easton DF; Ponder BA; Dunning AM
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):675-82. PubMed ID: 16614108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.
    Tinholt M; Viken MK; Dahm AE; Vollan HK; Sahlberg KK; Garred O; Børresen-Dale AL; Jacobsen AF; Kristensen V; Bukholm I; Kåresen R; Schlichting E; Skretting G; Lie BA; Sandset PM; Iversen N
    BMC Cancer; 2014 Nov; 14():845. PubMed ID: 25407022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
    Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.
    Garcia-Closas M; Kristensen V; Langerød A; Qi Y; Yeager M; Burdett L; Welch R; Lissowska J; Peplonska B; Brinton L; Gerhard DS; Gram IT; Perou CM; Børresen-Dale AL; Chanock S
    Int J Cancer; 2007 Dec; 121(11):2532-8. PubMed ID: 17683073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
    Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
    Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
    Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
    Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
    Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
    Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
    Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.
    Yamamoto-Ibusuki M; Yamamoto Y; Fujiwara S; Sueta A; Yamamoto S; Hayashi M; Tomiguchi M; Takeshita T; Iwase H
    Eur J Hum Genet; 2015 Jul; 23(7):949-56. PubMed ID: 25370037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
    Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
    J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk.
    Gaudet MM; Chanock S; Lissowska J; Berndt SI; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Garcia-Closas M
    Cancer Res; 2006 Oct; 66(19):9781-5. PubMed ID: 17018638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies.
    Feigelson HS; Cox DG; Cann HM; Wacholder S; Kaaks R; Henderson BE; Albanes D; Altshuler D; Berglund G; Berrino F; Bingham S; Buring JE; Burtt NP; Calle EE; Chanock SJ; Clavel-Chapelon F; Colditz G; Diver WR; Freedman ML; Haiman CA; Hankinson SE; Hayes RB; Hirschhorn JN; Hunter D; Kolonel LN; Kraft P; LeMarchand L; Linseisen J; Modi W; Navarro C; Peeters PH; Pike MC; Riboli E; Setiawan VW; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D
    Cancer Res; 2006 Feb; 66(4):2468-75. PubMed ID: 16489054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.
    Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
    Cancer Causes Control; 2015 Jan; 26(1):121-31. PubMed ID: 25421376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.